Skip to content
Clinical Trials – home
Sponsor

Nuvation Bio Inc.

United States 1500 Broadway Suite 1401, 10036-4055, United States

About the sponsor

Nuvation Bio Inc. focuses its clinical research activity on non-small cell lung cancer, with particular attention to advanced and metastatic disease. The sponsor’s trial portfolio is centered on ROS1-positive lung cancer, reflecting a targeted interest in molecularly defined thoracic oncology.

  • ROS1-positive NSCLC
  • Advanced and metastatic lung cancer
  • Targeted oncology

The research landscape includes international participation across multiple countries and collaborating sites, indicating an active focus on global oncology development within this disease area.

About Specializations

Nuvation Bio Inc. runs clinical trials in conditions such as Non-small cell lung cancer recurrent, Non-small cell lung cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study of Taletrectinib for Patients with Advanced or Metastatic ROS1 Positive Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Taletrectinib
  • Sponsor:Nuvation Bio Inc.

Non-small cell lung cancer

Not yet recruiting

Phase 3 Study of Taletrectinib as Adjuvant Therapy in Patients with Completely Resected ROS1‑Positive Stage IB‑IIIA Non‑Small Cell Lung Cancer

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Taletrectinib
  • Sponsor:Nuvation Bio Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.